RCM
WINT

Rotella Capital Management’s Windtree Therapeutics Inc WINT Stock Holding History

Rotella Capital Management’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,394
Closed -$23K – 668
2015
Q1 		$23K Buy
1,394
+529
+61% +$10.4K 0.02% 489
2014
Q4 		$14K Sell
865
-825
-49% -$18.1K 0.01% 354
2014
Q3 		$44K Sell
1,690
-563
-25% -$13.6K 0.05% 254
2014
Q2 		$56K Buy
+2,253
New +$57.6K 0.05% 298
2013
Q4 		– Sell
-1,167
Closed -$32K – 159
2013
Q3 		$32K Buy
1,167
+446
+62% +$10.8K 0.06% 104
2013
Q2 		$15K Buy
+721
New +$17.8K 0.05% 142

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Rotella Capital Management's WINT Position: Q2 2015 in Review

Rotella Capital Management sold out of Windtree Therapeutics Inc (WINT) in Q2 2015, closing a stake of 1,394 shares — an estimated $23K sold.

Rotella Capital Management first reported a position in WINT in Q2 2013 and held it in 6 quarters. The position peaked at $56K in Q2 2014. 52 funds tracked by Wall St. Rank hold WINT as of Q2 2015.

  • Rotella Capital Management reported no remaining Windtree Therapeutics Inc position as of Q2 2015 after selling out during the quarter.
  • Rotella Capital Management sold 1,394 Windtree Therapeutics Inc shares in Q2 2015, an estimated $23K.
  • Rotella Capital Management first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 6 quarters.
  • Rotella Capital Management's Windtree Therapeutics Inc position peaked at $56K in Q2 2014.
  • 52 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2015.

Based on Rotella Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.